125 related articles for article (PubMed ID: 18312221)
1. Classification of breast cancer versus normal samples from mass spectrometry profiles using linear discriminant analysis of important features selected by random forest.
Datta S
Stat Appl Genet Mol Biol; 2008; 7(2):Article7. PubMed ID: 18312221
[TBL] [Abstract][Full Text] [Related]
2. Application of the random forest classification method to peaks detected from mass spectrometric proteomic profiles of cancer patients and controls.
Barrett JH; Cairns DA
Stat Appl Genet Mol Biol; 2008; 7(2):Article4. PubMed ID: 18312218
[TBL] [Abstract][Full Text] [Related]
3. Support vector machine approach to separate control and breast cancer serum samples.
Pham TV; van de Wiel MA; Jimenez CR
Stat Appl Genet Mol Biol; 2008; 7(2):Article11. PubMed ID: 18312216
[TBL] [Abstract][Full Text] [Related]
4. Developing a discrimination rule between breast cancer patients and controls using proteomics mass spectrometric data: a three-step approach.
Heidema AG; Nagelkerke N
Stat Appl Genet Mol Biol; 2008; 7(2):Article5. PubMed ID: 18312219
[TBL] [Abstract][Full Text] [Related]
5. A classification model for the Leiden proteomics competition.
Hoefsloot HC; Smit S; Smilde AK
Stat Appl Genet Mol Biol; 2008; 7(2):Article8. PubMed ID: 18312222
[TBL] [Abstract][Full Text] [Related]
6. Feature extraction and dimensionality reduction for mass spectrometry data.
Liu Y
Comput Biol Med; 2009 Sep; 39(9):818-23. PubMed ID: 19646687
[TBL] [Abstract][Full Text] [Related]
7. Combined experimental and statistical strategy for mass spectrometry based serum protein profiling for diagnosis of breast cancer: a case-control study.
Callesen AK; Vach W; Jørgensen PE; Cold S; Tan Q; Depont Christensen R; Mogensen O; Kruse TA; Jensen ON; Madsen JS
J Proteome Res; 2008 Apr; 7(4):1419-26. PubMed ID: 18303830
[TBL] [Abstract][Full Text] [Related]
8. Detection of colorectal cancer using MALDI-TOF serum protein profiling.
de Noo ME; Mertens BJ; Ozalp A; Bladergroen MR; van der Werff MP; van de Velde CJ; Deelder AM; Tollenaar RA
Eur J Cancer; 2006 May; 42(8):1068-76. PubMed ID: 16603345
[TBL] [Abstract][Full Text] [Related]
9. Discrimination analysis of mass spectrometry proteomics for ovarian cancer detection.
Hong YJ; Wang XD; Shen D; Zeng S
Acta Pharmacol Sin; 2008 Oct; 29(10):1240-6. PubMed ID: 18817630
[TBL] [Abstract][Full Text] [Related]
10. Empirical Bayes logistic regression.
Strimenopoulou F; Brown PJ
Stat Appl Genet Mol Biol; 2008; 7(2):Article9. PubMed ID: 18312223
[TBL] [Abstract][Full Text] [Related]
11. MALDI-TOF serum protein profiling for the detection of breast cancer.
de Noo ME; Deelder A; van der Werff M; Ozalp A; Mertens B; Tollenaar R
Onkologie; 2006 Nov; 29(11):501-6. PubMed ID: 17068384
[TBL] [Abstract][Full Text] [Related]
12. Identification of lung cancer patients by serum protein profiling using surface-enhanced laser desorption/ionization time-of-flight mass spectrometry.
Han KQ; Huang G; Gao CF; Wang XL; Ma B; Sun LQ; Wei ZJ
Am J Clin Oncol; 2008 Apr; 31(2):133-9. PubMed ID: 18391596
[TBL] [Abstract][Full Text] [Related]
13. [Clinical significance of serum proteomic patterns in diagnosis of breast cancer].
Liu DH; Zhang LM; Feng WY
Zhonghua Zhong Liu Za Zhi; 2006 Oct; 28(10):770-1. PubMed ID: 17366791
[No Abstract] [Full Text] [Related]
14. Case-control breast cancer study of MALDI-TOF proteomic mass spectrometry data on serum samples.
van der Werff MP; Mertens B; de Noo ME; Bladergroen MR; Dalebout HC; Tollenaar RA; Deelder AM
Stat Appl Genet Mol Biol; 2008; 7(2):Article2. PubMed ID: 18241195
[TBL] [Abstract][Full Text] [Related]
15. An extended Markov blanket approach to proteomic biomarker detection from high-resolution mass spectrometry data.
Oh JH; Gurnani P; Schorge J; Rosenblatt KP; Gao JX
IEEE Trans Inf Technol Biomed; 2009 Mar; 13(2):195-206. PubMed ID: 19126475
[TBL] [Abstract][Full Text] [Related]
16. Organizing a competition on clinical mass spectrometry based proteomic diagnosis.
Mertens B
Stat Appl Genet Mol Biol; 2008; 7(2):Article3. PubMed ID: 18312217
[TBL] [Abstract][Full Text] [Related]
17. Principal component discriminant analysis.
Fearn T
Stat Appl Genet Mol Biol; 2008; 7(2):Article6. PubMed ID: 18312220
[TBL] [Abstract][Full Text] [Related]
18. Novel breast cancer biomarkers identified by integrative proteomic and gene expression mapping.
Ou K; Yu K; Kesuma D; Hooi M; Huang N; Chen W; Lee SY; Goh XP; Tan LK; Liu J; Soon SY; Bin Abdul Rashid S; Putti TC; Jikuya H; Ichikawa T; Nishimura O; Salto-Tellez M; Tan P
J Proteome Res; 2008 Apr; 7(4):1518-28. PubMed ID: 18318472
[TBL] [Abstract][Full Text] [Related]
19. Proteomic data analysis workflow for discovery of candidate biomarker peaks predictive of clinical outcome for patients with acute myeloid leukemia.
Forshed J; Pernemalm M; Tan CS; Lindberg M; Kanter L; Pawitan Y; Lewensohn R; Stenke L; Lehtiö J
J Proteome Res; 2008 Jun; 7(6):2332-41. PubMed ID: 18452325
[TBL] [Abstract][Full Text] [Related]
20. How to distinguish healthy from diseased? Classification strategy for mass spectrometry-based clinical proteomics.
Hendriks MM; Smit S; Akkermans WL; Reijmers TH; Eilers PH; Hoefsloot HC; Rubingh CM; de Koster CG; Aerts JM; Smilde AK
Proteomics; 2007 Oct; 7(20):3672-80. PubMed ID: 17880000
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
